iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
0.8146
-0.0104 (-1.26%)
At close: Jul 11, 2025, 4:00 PM
0.8000
-0.0146 (-1.79%)
After-hours: Jul 11, 2025, 7:57 PM EDT

iBio, Inc. Market Cap

iBio, Inc. has a market cap or net worth of $13.21 million as of July 11, 2025. Its market cap has decreased by -26.60% in one year.

Market Cap
13.21M
Enterprise Value
12.57M
1-Year Change
-26.60%
Ranking
Category
Stock Price
$0.81

Market Cap Chart

Since November 16, 2009, iBio, Inc.'s market cap has decreased from $27.70M to $13.21M, a decrease of -52.30%. That is a compound annual growth rate of -4.62%.

History

DateMarket Cap% Change
Jul 10, 202513.60M-39.29%
Dec 31, 202422.40M1,078.95%
Dec 29, 20231.90M-52.50%
Dec 30, 20224.00M-96.66%
Dec 31, 2021119.70M-37.40%
Dec 31, 2020191.20M2,320.25%
Dec 31, 20197.90M-43.57%
Dec 31, 201814.00M-14.63%
Dec 29, 201716.40M-53.41%
Dec 30, 201635.20M-18.71%
Dec 31, 201543.30M-12.17%
Dec 31, 201449.30M128.24%
Dec 31, 201321.60M-27.03%
Dec 31, 201229.60M10.04%
Dec 30, 201126.90M-73.23%
Dec 31, 2010100.50M298.81%
Dec 31, 200925.20M-9.03%
View and export this data all the way back to 2009. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 709.43B
Johnson & Johnson 378.84B
AbbVie 345.16B
Novo Nordisk 308.58B
UnitedHealth Group 273.92B
Novartis AG 240.09B
Abbott Laboratories 232.50B
AstraZeneca 218.25B
Market Cap Rankings